6,088 Shares in Biogen Inc. (NASDAQ:BIIB) Purchased by Summit Global Investments

Summit Global Investments purchased a new stake in Biogen Inc. (NASDAQ:BIIB – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 6,088 shares of the biotechnology company’s stock, valued at approximately $1,575,000. Several other institutional investors have also recently made changes to […]

Related Keywords

Germany ,United States ,Erick Rowinsky ,Priya Singhal ,Great Valley Advisor Group Inc ,First Trust Direct Indexing ,Nasdaq ,Biogen Inc ,Hexagon Capital Partners ,Needham Company ,Wells Fargo Company ,Securities Exchange Commission ,Summit Global Investments ,Free Report ,Valley Advisor Group ,Wealth Partners ,Capital Partners ,Director Eric ,Wells Fargo ,Get Free Report ,Visit Holdingschannel ,Biogen Daily ,Biogen ,Nasdaq Biib ,Biib ,Medical ,09062x10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,